Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States.

Davies, Jessica; Reyes-Rivera, Irmarie; Pattipaka, Thirupathi; Skirboll, Stephen; Ugiliweneza, Beatrice; Woo, Shiao; Boakye, Maxwell; Abrey, Lauren; Garcia, Josep; Burton, Eric

Davies, Jessica; Reyes-Rivera, Irmarie; Pattipaka, Thirupathi; Skirboll, Stephen; Ugiliweneza, Beatrice; Woo, Shiao; Boakye, Maxwell; Abrey, Lauren; Garcia, Josep; Burton, Eric.

Afiliación

Davies J; F. Hoffmann-La Roche Ltd, Welwyn Garden City, UK.
Reyes-Rivera I; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Pattipaka T; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Skirboll S; Stanford University Medical Center, Stanford, California, USA.
Ugiliweneza B; University of Louisville School of Medicine, Louisville, Kentucky, USA.
Woo S; University of Louisville School of Medicine and James Graham Brown Cancer Center, Louisville, Kentucky, USA (S.W.).
Boakye M; University of Louisville School of Medicine, Louisville, Kentucky, USA.
Abrey L; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Garcia J; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Burton E; University of Louisville School of Medicine, Louisville, Kentucky, USA.

Neurooncol Pract ; 5(4): 251-261, 2018 Nov.

Article en En | MEDLINE | ID: mdl-31385957

Palabras clave

SEER-Medicare; bevacizumab; elderly; glioblastoma; survival

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Pract Año: 2018 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google